China NT Pharma Group Company Limited (1011.HK)
1011.HK Stock Price Chart
Explore China NT Pharma Group Company Limited interactive price chart. Choose custom timeframes to analyze 1011.HK price movements and trends.
1011.HK Company Profile
Discover essential business fundamentals and corporate details for China NT Pharma Group Company Limited (1011.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
20 Apr 2011
Employees
22.00
Website
https://www.ntpharma.comCEO
Tit Ng
Description
China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products and generic drugs. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Suzhou, the People's Republic of China.
1011.HK Financial Timeline
Browse a chronological timeline of China NT Pharma Group Company Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Mar 2025
EPS came in at -$0.22 , while revenue for the quarter reached $7.09M .
Earnings released on 30 Aug 2024
EPS came in at $0.00 , while revenue for the quarter reached $33.61M .
Stock split effective on 18 Jul 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 3 Jul 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Mar 2024
EPS came in at -$0.77 .
Earnings released on 1 Sept 2023
EPS came in at -$0.00 , while revenue for the quarter reached $7.97M , missing expectations by -99.49%.
Earnings released on 1 Apr 2023
EPS came in at -$0.02 , while revenue for the quarter reached $98.62M , missing expectations by -93.63%.
Earnings released on 31 Aug 2022
EPS came in at -$0.02 , while revenue for the quarter reached $141.07M , missing expectations by -90.89%.
Earnings released on 31 Dec 2021
EPS came in at -$0.10 , while revenue for the quarter reached $141.37M .
Earnings released on 30 Jun 2021
EPS came in at -$0.00 , while revenue for the quarter reached $133.55M .
Earnings released on 31 Dec 2020
EPS came in at -$0.09 , while revenue for the quarter reached $157.12M .
1011.HK Stock Performance
Access detailed 1011.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.